Revise preauthorization laws relating to healthcare

Removed placeholder bracketed text specifying the exact effective date and the date claims must be submitted for the law to apply.

Converted the document from a draft legislative print to an enrolled bill format, including signatures from the House and Senate leadership and the Chief Clerk.

Removed redundant headers and footers found in the draft version to align with the final enrolled bill format.

Added a provision stating the department cannot be required to cover antipsychotic drugs that are not eligible for coverage under federal Medicaid law (42 U.S.C. 1396R-8).

Reorganized the text to clarify that prior authorization restrictions apply only to antipsychotic drugs approved by the FDA and recognized in the Diagnostic and Statistical Manual of Mental Disorders.

Adjusted the effective date and applicability sections to reflect the new scope of the act.

Added a requirement for the department to cover FDA-approved antipsychotic drugs for Medicaid members aged 18 and older without requiring prior authorization.

Added a provision stating that the department cannot cover antipsychotic drugs that are not eligible for coverage under federal Medicaid law (42 U.S.C. 1396R-8).

Reorganized the bill structure, splitting the original single section into multiple sections and adding a new Section 2 regarding the effective date.

Updated bill number from LC 4187 to HB 610.1 and added the primary sponsor's name, K. Seekins-Crowe.

Minor grammatical adjustment in Section 1 to improve sentence structure by adding 'The' at the beginning of the department's directive.